A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Public ClinicalTrials.gov record NCT05224102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV, Multicenter, Open-Label, Single-Arm Study to Investigate Faricimab (RO6867461) Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander; in addition, a cohort of Asian Indian participants will be enrolled in India.
Study identification
- NCT ID
- NCT05224102
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2022 (Actual)
- Primary completion
- Jan 26, 2027 (Estimated)
- Completion
- Jan 26, 2027 (Estimated)
- Last update posted
- Aug 25, 2026
2022 – 2027
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barnet Dulaney Perkins Eye Center | Phoenix | Arizona | 85016 | — |
| Win Retina | Arcadia | California | 91006 | — |
| Retinal Diagnostic Center | Campbell | California | 95008 | — |
| Retina Consultants of Orange County | Fullerton | California | 92835 | — |
| Kaiser Permanente Southern California | Los Angeles | California | 90027 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95841-2013 | — |
| Southwest Retina Consultants | Durango | Colorado | 81303 | — |
| Emerson Clinical Research Institute LLC | Washington D.C. | District of Columbia | 20011-3010 | — |
| Blue Ocean Clinical Research | Clearwater | Florida | 33761-2046 | — |
| Retina Macula Specialists of Miami - LeJeune Road Office | Miami | Florida | 33126-5690 | — |
| Florida Retina Institute | Orlando | Florida | 32806-1101 | — |
| Fort Lauderdale Eye Institute | Plantation | Florida | 33324 | — |
| University Retina and Macula Associates, PC | Oak Forest | Illinois | 60452 | — |
| Wilmer Eye Institute Johns Hopkins University | Baltimore | Maryland | 21287-0005 | — |
| Md Medical Research | Oxon Hill | Maryland | 20745 | — |
| Retina Associates of Michigan | Grand Blanc | Michigan | 48439-8301 | — |
| Retina Consultants of Nevada | Henderson | Nevada | 89052 | — |
| Sierra Eye Associates | Reno | Nevada | 89502 | — |
| The Retina Center of New Jersey | Bloomfield | New Jersey | 07003-3000 | — |
| NJ Retina - Teaneck | Teaneck | New Jersey | 07666-1704 | — |
| Piedmont Retina Specialists | Winston-Salem | North Carolina | 27103-6970 | — |
| Retina Associates of Cleveland, INC | Beachwood | Ohio | 44122-7340 | — |
| Scheie Eye Institute | Philadelphia | Pennsylvania | 19104 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Black Hills Eye Institute | Rapid City | South Dakota | 57701 | — |
| Charles Retina Institute | Memphis | Tennessee | 38119 | — |
| Austin Clinical Research LLC | Austin | Texas | 78750 | — |
| Retina & Vitreous of Texas | Bellaire | Texas | 77401-3510 | — |
| Retina Consultants of Texas Westover Hills Retina Center | San Antonio | Texas | 78251 | — |
| Retina Center of Texas | Southlake | Texas | 76092 | — |
| Strategic Clinical Research Group, LLC | Willow Park | Texas | 76087 | — |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | — |
| Wagner Kapoor Institute | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05224102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05224102 live on ClinicalTrials.gov.